What's in Rowpar Pharmaceuticals, Inc.'s pipeline?

Rowpar Pharmaceuticals, Inc. has 4 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 2 in Phase 1.

Which companies overlap with Rowpar Pharmaceuticals, Inc.'s portfolio?

Top competitors by shared drug class: GlaxoSmithKline, Johnson & Johnson Consumer Inc. (J&JCI), Universidade Estadual Paulista Júlio de Mesquita Filho, University of Oslo.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/rowpar-pharmaceuticals-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Rowpar Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Rowpar Pharmaceuticals, Inc. pipeline: 1 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 1 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Stabilized chlorine dioxide oral rinse	Stabilized chlorine dioxide oral rinse	marketed	Antimicrobial oral rinse		Oral Health / Dentistry

Therapeutic area mix

Dentistry · 1
Oral Health / Dentistry · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

GlaxoSmithKline · 2 shared drug classes
Johnson & Johnson Consumer Inc. (J&JCI) · 1 shared drug class
Universidade Estadual Paulista Júlio de Mesquita Filho · 1 shared drug class
University of Oslo · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Rowpar Pharmaceuticals, Inc.:

Cite this brief

Drug Landscape (2026). Rowpar Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/rowpar-pharmaceuticals-inc. Accessed 2026-06-10.